ÂÜÀòÂÒÂ×

Chia Wen Lee is a seasoned professional in the fields of market access, pricing, and health economics with extensive experience in the pharmaceutical industry. Currently serving as a Business Consultant at Viatris since June 2024, Chia's prior roles include Vice President of Global Market Access & Pricing and HEOR at Moderna from May 2021 to May 2024, and Head of Global Market Access & Pricing for the Dupixent franchise at Sanofi Genzyme from July 2017 to May 2021, where leadership contributed to achieving a business target exceeding $10 billion. Additional experience includes senior roles at Merck, Boehringer Ingelheim, Biogen, Pfizer, and a research fellowship at the National Institute for Health and Care Excellence. Chia holds a PhD in Epidemiology & Biostatistics from the London School of Hygiene and Tropical Medicine, an MS in Evidence-Based Health Care from the University of Oxford, and an MS in Nutrition from King's College London.